IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bellevue Group AG

Q3 2020 Holdings

Filed 2020-11-16 | 261 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$2.4M8,6000.2%
Abbvie Inc(ABBV)COM00287Y109$3.2M37,0000.3%
Biontech SE(BNTX)SPONSORED ADS09075V102$3.4M49,5000.3%
Avantor Inc(AVTR)COM05352A100$6.9M307,0890.6%
Beigene LTD(ONC)SPONSORED ADR07725L102$11.3M39,4001.0%
Coherus Biosciences Inc(CHRS)COM19249H103$25.7M1,403,4002.4%
Align Technology Inc(ALGN)COM016255101$27.7M84,6352.5%
Arvinas Inc(ARVN)COM04335A105$38.8M1,641,5033.5%
BIO RAD Labs Inc(BIO)CL A090572207$40.3M78,1863.7%
Caredx Inc(CDNA)COM14167L103$42.3M1,115,9033.9%
Black Diamond Therapeutics I(BDTX)COM09203E105$42.4M1,403,0003.9%
Centene Corp del(CNC)COM15135B101$60.3M1,033,6475.5%
Boston Scientific Corp(BSX)COM101137107$72.1M1,886,2976.6%
Charles RIV Labs Intl Inc(CRL)COM159864107$79.5M351,0837.3%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$145.3M4,151,00213.3%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$227.1M1,559,80520.8%
Argenx SE(ARGX)SPONSORED ADR04016X101$251.8M959,01623.0%
PreviousPage 5 of 5